The HydRx Farms subsidiary of Scientus Pharma has received its Access to Cannabis for Medical Purposes Regulations (ACMPR) license from Health Canada.
Scientus now is permitted to begin cultivating medicinal cannabis at its 45,000 square foot commercial production facility at Whitby, Ontario. Scientus is the 59th company in Canada to receive a cultivation license from Health Canada under the ACMPR program.
“Achieving licensed producer status is an important milestone and central to our strategy of being the first company to make the leap from medical-grade to pharmaceutical-grade cannabinoid product development and commercialization,” CEO, Trevor Folk, said in a statement.
